AHN Breakthrough

Five Huntsman Cancer Institute at the University of Utah colleagues earned endowed chair appointments, including new appointments.

A 3-year, $225K award will focus on improving quality of life for patients living with long-term effects of cancer treatment.

Bringing some or all clinical trial-related activities directly to patients can help overcome barriers that prevent many people from participating.

Roswell Park Comprehensive Cancer Center investigators will deliver 21 presentations at the AHNS 12th International Conference on Head and Neck Cancer.

A research team from Huntsman Cancer Institute at the University of Utah showed a pathway-targeted therapy that could be an effective melanoma treatment.

A gene expression test identified the first 3 years after childbirth as a potential window of higher biological risk in breast cancer.

An MD Anderson Cancer Center study identified a new link between immune cells and a copper-induced form of cell death called cuproptosis.

A triplet combination regimen led to high remission rates in patients with blastic plasmacytoid dendritic cell neoplasm.